Sabra Health Care REIT (SBRA) EBIT Margin (2016 - 2026)

Sabra Health Care REIT's EBIT Margin history runs 11 years deep, the most recent figure standing at 58.13% for Q1 2026.

• In Q1 2026, EBIT Margin fell 2916.0% year-over-year to 58.13%; the TTM figure through Mar 2026 stood at 53.27% (up 153980.0% YoY), while the FY2025 annual figure was 34.33%, down 5121.0% from the prior year.
• EBIT Margin was 58.13% for Q1 2026 at Sabra Health Care REIT, up from 25.93% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 162.66% in Q1 2022 to a low of 31.85% in Q4 2024.
• Historically, EBIT Margin has averaged 54.36% across 5 years, with a median of 58.13% in 2026.
• The sharpest annual moves came in 2022 and 2023: EBIT Margin surged 12095 bps in 2022, then slumped 14991 bps in 2023.
• A 5-year view of EBIT Margin shows it stood at 11.49% in 2022, then soared by 759 bps to 75.71% in 2023, then plunged by 142 bps to 31.85% in 2024, then jumped by 181 bps to 25.93% in 2025, then surged by 124 bps to 58.13% in 2026.
• The last three EBIT Margin figures came in at 58.13% (Q1 2026), 25.93% (Q4 2025), and 55.02% (Q3 2025), per Business Quant data.